10-Q/A XBRL

CHROMADEX FORM 10-Q/A

Company: Niagen Bioscience, Inc.
Filed: December 5, 2013
Period of Report: June 29, 2013
Accession Number: 0001415889-13-002525

View Document ↗ View on SEC.gov ↗